Dr. Zeldin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 Eagle Ridge Way
West Orange, NJ 07052Phone+1 347-944-9846
Summary
- Dr. Gillian Zeldin is a transplant hepatologist in West Orange, NJ. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 26 years. She specializes in hepatology & liver transplantation medicine and is experienced in hepatology, transplant hepatology, biliary tract disease, amyloidosis, and hematologic oncology.
Education & Training
- Johns Hopkins UniversityFellowship, Gastroenterology, 1994 - 1998
- UPMC Medical EducationResidency, Internal Medicine, 1991 - 1994
- Rutgers Robert Wood Johnson Medical SchoolClass of 1991
- Trenton State CollegeBA, Biology, 1982 - 1985
Certifications & Licensure
- NJ State Medical License 2005 - 2023
- PA State Medical License 1998 - 2006
Publications & Presentations
PubMed
- 96 citationsChronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue.Huizhi Lin, Shiqi Yang, Gillian Ann Zeldin, Anna Mae Diehl
Alcoholism, Clinical and Experimental Research. 1998-08-01 - 61 citationsThe outcome of liver grafts procured from hepatitis C-positive donors.Ergun Velidedeoglu, Niraj M. Desai, Louis Campos, Kim M. Olthoff, Abraham Shaked
Transplantation. 2002-02-27 - 54 citationsAlcohol and Cytokine-inducible Transcription FactorsGillian Ann Zeldin, Shiqi Yang, Ming Yin, Hui Zhi Lin, Rudra Rai
Alcoholism, Clinical and Experimental Research. 1996-12-01
Journal Articles
- What is the best immunosuppression in living donor liver transplantation?Ringe B, Moritz M, Zeldin G, Soriano H., Transplantation Proceedings, 1/1/2005
- Safety and Efficacy of Living Donor Liver Preservation with HTK SolutionRinge B, Braun F, Moritz M, Zeldin G, Soriano, Meyers W., Transplantation Proceedings, 1/1/2005
- Effect of donor hepatitis C on liver graft survivalVelidedeoglu E, Desai NM, Campos L, Olthoff KM, Shaked A, Nunes F, Zeldin G, Stewart C, Blumberg E, Abrams J, Markmann JF, Transplant Proc., 1/1/2001
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- What is the Best Immunosuppression in Live Donor Liver Transplantation?Ringe B, Moritz M, Zeldin Z, Soriano H, American Society of Transplant Surgeons, Miami Beach, Florida, 1/1/2005
- The outcome of livers from HCV positive donors.Velidedeoglu E, Desai N, Campos L, Olthoff K, Shaked A, Forman L, Zeldin GA, Stewart C, Nunes F, Blumberg E, Abrams J, Lucey M., American Society of Transplantation, Chicago, Illinois, 1/1/2001
- Outcome of transplantation of marginal liver grafts in high-need patients: evaluation of physician based organ allocation.Markmann J, Velidedeoglu E, Olthoff K, Shaked A, Zamir G, Stewart C, Zeldin GA, Nunes F, Schultz C, Burke A, Hibbler J, Kovalovich K, Abrams J, Lucey M, American Society of Transplantation, Chicago, Illinois, 1/1/2000
- Join now to see all
Lectures
- HCV/HBV therapeutics and patient managementAtlanta, Georgia - 1/9./1998
- Acute/Fulminant Hepatic FailureDrexel University College of Medicine Philadelphia, PA - 1/21/2004
- Liver Transplant Candidacy EvaluationDrexel University College of Medicine Philadelphia, PA - 1/21/2004
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: